Nuvig, Maze, and Antag close funding rounds In other financing news this week, immunomodulation therapy developer Nuvig Therapeutics ... and Nuvig's preclinical pipeline. NVG-2089 is designed ...

The company also has several candidates in its pipeline as can be seen above. United Therapeutics is trying to position Tyvaso to treat idiopathic pulmonary fibrosis, where it would have Orphan ...

Black Diamond Therapeutics's novel EGFR inhibitor shows promise in addressing resistance mutations in NSCLC and glioblastoma.

Kate Therapeutics' pipeline is still in the preclinical stage of development but includes candidates for DMD, facioscapulohumeral dystrophy (FSHD), and myotonic dystrophy type 1 (DM1), as well as ...

The U.S. flag is seen on a building on Wall St. in the financial district in New York, U.S., November 24, 2020. REUTERS/Brendan McDermid/File Photo The U.S. stock rebound has driven key indexes to ...

Read all the stories you want.